NCT05396209 is a NA clinical trial of Hydrated Amniotic Membrane Plug in Macular Holes, sponsored by Oriental Neurosurgery Evidence-Based-Study Team.

Who is sponsoring NCT05396209?

NCT05396209 is sponsored by Oriental Neurosurgery Evidence-Based-Study Team.

What drugs are being tested in NCT05396209?

Interventions in NCT05396209: Hydrated Amniotic Membrane Plug, ILM filling, Conventional ILM peeling.

What condition does NCT05396209 study?

NCT05396209 studies Macular Holes.

Is NCT05396209 still recruiting?

NCT05396209 is currently status unknown. Last updated 31 May 2022.

Last reviewed 2022-05-31 · How we verify

NCT05396209

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes.

Status unknown NA Last updated 31 May 2022

What this trial tests

NA trial testing Hydrated Amniotic Membrane Plug in Macular Holes in 80 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
15 May 2024

15 June 2025

Quick facts

Lead sponsor	Oriental Neurosurgery Evidence-Based-Study Team
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	1 June 2022
Primary completion	15 May 2024
Estimated completion	15 June 2025
Sites	1 location across China

Drugs / interventions tested

Hydrated Amniotic Membrane Plug
ILM filling
Conventional ILM peeling

Conditions studied

Macular Holes — all drugs for Macular Holes →

Sponsor

Oriental Neurosurgery Evidence-Based-Study Team — full company profile →

Who can join

18 and older, any sex, with Macular Holes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare anatomic and functional results, and to evaluate postoperatively the healing process in 3 different techniques for the closure of the refractory macular holes (MH).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Macular Holes

Currently open trials in the same condition.

NCT06211907 — Small Macular Holes Treated With Air · NA · recruiting
NCT06000111 — Duration of Face Down Positioning for Full-Thickness Macular Hole Repair · NA · recruiting
NCT04904679 — The Use of Amniotic Membrane or Internal Limiting Membrane for Large or Refractory Macular Holes: A Prospective Study · NA · active not recruiting
NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting

Other Oriental Neurosurgery Evidence-Based-Study Team trials

Trials by the same sponsor.

NCT06936514 — Clinical Study on Deep Cervical Lymphatic Trunk Decompression Combined With Mid-Cervical Deep Lymph Node-External Jugula · NA · enrolling by invitation
NCT03620552 — 18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia · EARLY_PHASE1 · unknown
NCT03555292 — 11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes · Phase 2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05396209 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oriental Neurosurgery Evidence-Based-Study Team
Last refreshed: 31 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05396209.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing